Targeting the Tumor Microenvironment with Gene-Engineered Immune Cells: Focus on CAR-Macrophages and CAR-NK Cells – A Review Article
The TME is a culprit of immunosuppression and a significant hurdle to long-term immunotherapeutic success in solid tumors, which are often associated with a dense stroma, hypoxia, and immunosuppressive myeloid and lymphoid cells. Conventional CAR-T cells tend to fail in this scenario as they are su...
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Health Innovation Press
2025-10-01
|
| Serie: | Health Innovation Reports |
| Soggetti: | |
| Accesso online: | https://healthinnovationpress.com/index.php/hir/article/view/54 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
